Nurix Therapeutics, Inc. (NRIX) has 74 open-market insider trades by 6 insiders since 2021. Over the last six months insiders net sold $922K. The most active filer is Hans van Houte, CFO.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Hans van Houte | CFO | — | 21 | $2.8M | 2026-08-04 |
| Pierre Beaurang | — | — | 7 | $1.7M | 2021-08-10 |
| Gwenn Hansen | CSO | — | 20 | $1.2M | 2026-10-15 |
| Christine Ring | CLO | — | 20 | $1.1M | 2026-10-02 |
| Julia P. Gregory | Dir | — | 1 | $529K | 2026-10-14 |
| Stefani Wolff | EVP and COO | — | 5 | $22K | 2023-05-01 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Gwenn Hansen | CSO | Sell | $36K | 2026-10-15 |
| Julia P. Gregory | Director | Sell | $529K | 2026-10-14 |
| Christine Ring | CLO | Sell | $134K | 2026-10-02 |
| Christine Ring | CLO | Sell | $149K | 2026-09-02 |
| Gwenn Hansen | CSO | Sell | $37K | 2026-09-01 |
| Gwenn Hansen | CSO | Sell | $109K | 2026-08-05 |
Companies that share insiders with NRIX, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| Gwenn Hansen | CSO | Sell | $100K | 2026-08-04 |
| Hans van Houte | CFO | Sell | $116K | 2026-08-04 |
| Christine Ring | CLO | Sell | $382K | 2026-08-03 |
| Gwenn Hansen | CSO | Sell | $90K | 2026-07-30 |
| Hans van Houte | CFO | Sell | $67K | 2026-07-30 |
| Christine Ring | CLO | Sell | $259K | 2026-07-02 |
| Christine Ring | CLO | Sell | $581K | 2026-06-25 |
| Gwenn Hansen | CSO | Sell | $108K | 2026-06-25 |
| Christine Ring | CLO | Sell | $135K | 2026-06-02 |